4G6F image
Deposition Date 2012-07-19
Release Date 2012-09-26
Last Version Date 2024-10-30
Entry Detail
PDB ID:
4G6F
Keywords:
Title:
Crystal Structure of 10E8 Fab in Complex with an HIV-1 gp41 Peptide
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.10 Å
R-Value Free:
0.21
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:10E8 Heavy Chain
Chain IDs:A (auth: H), B
Chain Length:236
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:10E8 Light Chain
Chain IDs:C (auth: L), D
Chain Length:215
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:gp41 MPER Peptide
Chain IDs:E (auth: P), F
Chain Length:34
Number of Molecules:2
Biological Source:Human immunodeficiency virus 1
Primary Citation
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody.
Nature 491 406 412 (2012)
PMID: 23151583 DOI: 10.1038/nature11544

Abstact

Characterization of human monoclonal antibodies is providing considerable insight into mechanisms of broad HIV-1 neutralization. Here we report an HIV-1 gp41 membrane-proximal external region (MPER)-specific antibody, named 10E8, which neutralizes ∼98% of tested viruses. An analysis of sera from 78 healthy HIV-1-infected donors demonstrated that 27% contained MPER-specific antibodies and 8% contained 10E8-like specificities. In contrast to other neutralizing MPER antibodies, 10E8 did not bind phospholipids, was not autoreactive, and bound cell-surface envelope. The structure of 10E8 in complex with the complete MPER revealed a site of vulnerability comprising a narrow stretch of highly conserved gp41-hydrophobic residues and a critical arginine or lysine just before the transmembrane region. Analysis of resistant HIV-1 variants confirmed the importance of these residues for neutralization. The highly conserved MPER is a target of potent, non-self-reactive neutralizing antibodies, suggesting that HIV-1 vaccines should aim to induce antibodies to this region of HIV-1 envelope glycoprotein.

Legend

Protein

Chemical

Disease

Primary Citation of related structures